Jardiance by Boehringer Ingelheim approved in India for the treatment of adults with CKD
This indication approval allows the nephrologists and cardiologists to use Jardiance 10mg tablets for the treatment of CKD in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Boehringer Ingelheim India
Boehringer Ingelheim India signs MoU with PPAM and BMC to ‘Stop Rabies’ in Mumbai
The ‘Stop Rabies’ initiative aligns with India's National Action Plan for Dog-Mediated Rabies Elimination by 2030
Boehringer Ingelheim India signs MoU with Maha Govt to strengthen stroke care
A pilot project on stroke detection and management will be launched in five districts - Thane, Auranagabad, Pune, Nanded and…
Boehringer Ingelheim India signs MoU with SIIC, IIT Kanpur for socially impactful innovations
The purpose of this collaboration is to extend support to significant innovations developed at SIIC, IIT Kanpur, with a specific…
Empagliflozin meets primary endpoint in Phase III heart failure trial
It reduced the risk of cardiovascular death or hospitalisation for heart failure versus placebo on top of standards of care in…